Prospect Financial Services LLC Acurx Pharmaceuticals, Inc. Transaction History
Prospect Financial Services LLC
- $183 Billion
- Q4 2024
A detailed history of Prospect Financial Services LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Prospect Financial Services LLC holds 329,076 shares of ACXP stock, worth $243,516. This represents 0.15% of its overall portfolio holdings.
Number of Shares
329,076
Previous 295,075
11.52%
Holding current value
$243,516
Previous $561 Million
52.22%
% of portfolio
0.15%
Previous 0.35%
Shares
5 transactions
Others Institutions Holding ACXP
# of Institutions
31Shares Held
1.36MCall Options Held
9.3KPut Options Held
9.7K-
Vanguard Group Inc Valley Forge, PA529KShares$391,7180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$108,4100.0% of portfolio
-
Morgan Stanley New York, NY106KShares$78,5880.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA48.4KShares$35,7960.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$32,1640.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $8.55M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...